Asthma is a disease characterized by a bronchial hyperresponsiveness (
BHR). Although the underlying mechanisms that induce this increase in
bronchial reactivity remain unknown, evidence suggests that the inflam
matory process present in the airways could play an important role in
the development of BHR. This latter may result from alterations in the
intrinsic properties of airway smooth muscle induced by inflammatory
mediators. Tumor necrosis factor alpha :(TNF alpha), a pro-inflammator
y cytokine, appears to be an interesting candidate considering on one
hand that it is able to induce, in human and in animals, a BHR to diff
erent inhaled pharmacological agents and on the other hand that high l
evels of TNF alpha were found in asthmatic airways. Our studies show t
hat TNF alpha induces in a direct manner somes modifications of the br
onchial smooth muscle which can underly an increased muscle contractil
ity. These modifications include an alteration of the intracellular ca
lcium homeostasis and an increase in the mitogen capacity of the human
airway smooth muscle cells. Using antibodies directed against the two
existing receptor type of TNF alpha (TNFRp55 and TNFRp75) and TNF alp
ha-analogs obtained by directed mutagenesis, we showed that these modi
fications result from the activation of TNFRp55. The implication of th
is receptor in the other pathophysiologic characteristics of asthma is
also discussed in this review.